CAS 68373-96-6

mazethramycin

Description:

Mazethramycin is a complex chemical compound classified as an antibiotic, specifically belonging to the class of macrolide antibiotics. It is produced by the fermentation of certain strains of Streptomyces bacteria. The substance exhibits a broad spectrum of antibacterial activity, particularly against Gram-positive bacteria, making it valuable in clinical applications. Mazethramycin functions by inhibiting bacterial protein synthesis, thereby impeding the growth and reproduction of susceptible microorganisms. Its structure features a large lactone ring, characteristic of macrolides, which contributes to its biological activity. The compound has been studied for its potential therapeutic uses, including its efficacy in treating various infections. However, like many antibiotics, its use may be limited by the development of resistance in bacterial populations. Safety and efficacy profiles are essential considerations in its application, and ongoing research continues to explore its full potential in medicine.

Formula: C₁₇H₁₉N₃O₄

InChI: InChI=1/C17H19N3O4/c1-9-3-5-11-14(15(9)22)19-16(23)12-7-10(4-6-13(21)18-2)8-20(12)17(11)24/h3-7,12,16,19,22-23H,8H2,1-2H3,(H,18,21)/b6-4+

Synonyms:

• 2-Propenamide, N-methyl-3-(5,10,11,11a-tetrahydro-9,11-dihydroxy-8-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl)- (9CI)
• N-Methyl-3-(5,10,11,11a-tetrahydro-9,11-dihydroxy-8-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepine-2-yl)propenamide
• mazethramycin
• Mezethramycin A
• Mazethramycin A

Mazethramycin

CAS: 68373-96-6

Mazethramycin is an antitumor antibiotic that exerts its effects by disrupting DNA replication and RNA synthesis within cells. It is utilized in cancer research.

Formula: C₁₇H₁₉N₃O₄

Molecular weight: 329.35

Ref: TM-TN11227